First Western Trust Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Sell
1,179
-36
-3% -$36.5K 0.05% 83
2025
Q4
$1.31M Buy
1,215
+22
+2% +$21K 0.06% 76
2025
Q3
$910K Sell
1,193
-10
-0.8% -$7.44K 0.04% 91
2025
Q2
$938K Sell
1,203
-198
-14% -$154K 0.04% 90
2025
Q1
$1.16M Sell
1,401
-8
-0.6% -$6.66K 0.06% 77
2024
Q4
$1.09M Sell
1,409
-25
-2% -$20.7K 0.05% 85
2024
Q3
$1.27M Buy
1,434
+7
+0.5% +$6.29K 0.06% 81
2024
Q2
$1.29M Sell
1,427
-53
-4% -$42.4K 0.06% 77
2024
Q1
$1.15M Sell
1,480
-189
-11% -$135K 0.05% 81
2023
Q4
$973K Buy
1,669
+93
+6% +$54.3K 0.05% 88
2023
Q3
$847K Sell
1,576
-222
-12% -$114K 0.05% 92
2023
Q2
$843K Sell
1,798
-243
-12% -$102K 0.04% 99
2023
Q1
$701K Sell
2,041
-89
-4% -$30K 0.04% 110
2022
Q4
$779K Sell
2,130
-141
-6% -$50K 0.04% 104
2022
Q3
$734K Sell
2,271
-141
-6% -$44.7K 0.05% 97
2022
Q2
$779K Sell
2,412
-48
-2% -$14.4K 0.05% 97
2022
Q1
$713K Buy
+2,460
New +$633K 0.04% 104

Other funds holding LLY

First Western Trust Bank's LLY Position: Q1 2026 in Review

First Western Trust Bank reduced its Eli Lilly (LLY) stake by 3% in Q1 2026, selling an estimated $36.5K and leaving 1,179 shares worth $1.08M. The position accounts for 0.05% of the portfolio, ranked #83.

First Western Trust Bank first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.31M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First Western Trust Bank held 1,179 shares of Eli Lilly worth $1.08M as of Q1 2026.
  • First Western Trust Bank sold 36 Eli Lilly shares in Q1 2026, an estimated $36.5K.
  • Eli Lilly made up 0.05% of First Western Trust Bank's portfolio in Q1 2026, its #83 holding.
  • First Western Trust Bank first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • First Western Trust Bank's Eli Lilly position peaked at $1.31M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Western Trust Bank's 13F filing for Q1 2026, filed 12 May 2026.